CARY, N.C., April 27, 2018 -- Chiesi is proud to be named the signature sponsor of the 2018 Triangle March for Babies Walk & 5K Run – the organization’s most recognized event in communities nationwide.
“We’re excited to sponsor because, each year, 15 million babies worldwide are born too soon,” said Jason Beyer, Sr. Director, Strategy & Corporate Development for Chiesi USA and Chairperson for the 2018 Triangle March for Babies Walk & 5K Run. “This year, we are expecting approximately 7,000 participants to join the Triangle walk, which has a goal to raise $650,000 to fight prematurity and provide support to families in the neonatal intensive care unit (NICU).”
The event begins at 10 a.m., on Saturday, April 28, in Perimeter Park, located at 3005 Carrington Mill Blvd., Morrisville.
Chiesi participants joining in this event for the fourth consecutive year include family and company teams, in addition to community members, who want to raise funds to help babies in the Triangle. Chiesi employees continue to find new ways to encourage participation and donations every year, from ice cream socials to raffles, contributing more than $165,000 as a corporate team since 2015.
“Offering opportunities for our employees to come together to support a cause we so firmly believe in is vital to the wellness of our organization and part of our Chiesi in the Community effort,” said Ken McBean, President of Chiesi USA. “Our commitment to neonatology, the community in which we live and the colleagues we work with go hand-in-hand with supporting the Triangle March for Babies. Our goal is to witness a continued positive impact in the health of communities we serve.”
To register for the event please visit www.marchforbabies.org/triangle.
About Chiesi USA
Chiesi USA, Inc., headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercialization of products for the hospital, rare disease and target office-based specialties. Key elements of the company’s strategy are to focus its commercial and development efforts in the hospital and adjacent specialty product sector within the U.S. pharmaceutical marketplace; continue to seek opportunities to acquire companies, marketed or registration-stage products and late-stage development products that fit within the Company's focus areas. Chiesi USA, Inc. is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A. For more information, visit www.chiesiusa.com.
About Chiesi in the Community
Chiesi in the Community is Chiesi USA’s employee-led corporate social responsibility program. The mission of the program is to improve the health and well-being of the communities where we live and serve. The program is comprised of four main pillars: Stakeholder Engagement, Local Sociocultural Enhancement, Therapeutic Areas and Keystone Initiative. Chiesi works with many nonprofits in the Triangle area focused on underserved youth. In addition to local nonprofit support, the company’s Keystone Initiative is focused on local elementary schools; working with staff, parents and local partners to implement sustainable programs designed to make positive change in the overall student learning experience. On a national scale, Chiesi continues to support the efforts of groups within the therapeutic areas they serve, such as the March of Dimes, American Heart Association and cystic fibrosis nonprofits.
About March of Dimes
March of Dimes leads the fight for the health of all moms and babies. We support research, lead programs and provide education and advocacy so that every baby can have the best possible start. Building on a successful 80-year legacy of impact and innovation, we empower every mom and every family.
For the latest resources and health information, visit our websites marchofdimes.org and nacersano.org. To participate in our annual signature fundraising event, visit marchforbabies.org/triangle. If you have been affected by prematurity or birth defects, visit our shareyourstory.org community to find comfort and support. For detailed national, state and local perinatal statistics, visit peristats.org. You can also Find us on Facebook and follow us on Instagram and Twitter.
Contacts
Media: FleishmanHillard, Elizabeth Romero, +1-919-457-0749, [email protected]
Business Development: Josh Franklin, +1-919-678-6520, [email protected]
PP-C-0140 V2.0


OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Japan Earthquake Disrupts Auto and Chip Supply Chains
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 



